Request for Covid-19 Impact Assessment of this Report
The United States Transient Receptor Potential Cation Channel Subfamily V Member 1 market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Transient Receptor Potential Cation Channel Subfamily V Member 1 market, reaching US$ million by the year 2028. As for the Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Transient Receptor Potential Cation Channel Subfamily V Member 1 players cover Amgen Inc, Amorepacific Corp, BCN Peptides SA, and Centrexion Therapeutics Corp, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Transient Receptor Potential Cation Channel Subfamily V Member 1 market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
CMX-020
CA-016
DD-04107
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Ophthalmology
Immunology
Muscle Spasm
Pruritus
Abdominal Pain
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Amgen Inc
Amorepacific Corp
BCN Peptides SA
Centrexion Therapeutics Corp
Daewoong Pharmaceutical Co Ltd
DoNatur GmbH
Flex Pharma Inc
Grunenthal GmbH
Kyowa Hakko Kirin Co Ltd
Medifron DBT Co Ltd
Neurim Pharmaceuticals Ltd
Pila Pharma AB
Sylentis SAU
Toray Industries Inc
Vitality Biopharma Inc
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2017-2028
2.1.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Type
2.2.1 CMX-020
2.2.2 CA-016
2.2.3 DD-04107
2.2.4 Others
2.3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type
2.3.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)
2.4 Transient Receptor Potential Cation Channel Subfamily V Member 1 Segment by Application
2.4.1 Ophthalmology
2.4.2 Immunology
2.4.3 Muscle Spasm
2.4.4 Pruritus
2.4.5 Abdominal Pain
2.4.6 Others
2.5 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application
2.5.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)
3 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Player
3.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Players
3.1.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players (2020-2022)
3.1.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Players (2020-2022)
3.2 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Transient Receptor Potential Cation Channel Subfamily V Member 1 by Regions
4.1 Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Regions (2017-2022)
4.2 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth (2017-2022)
4.3 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth (2017-2022)
4.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth (2017-2022)
4.5 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth (2017-2022)
5 Americas
5.1 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022)
5.2 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022)
5.3 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2017-2022)
6.2 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022)
6.3 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 by Country (2017-2022)
7.2 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022)
7.3 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 by Region (2017-2022)
8.2 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022)
8.3 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Regions (2023-2028)
10.1.1 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Regions (2023-2028)
10.1.2 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast
10.1.3 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast
10.1.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast
10.1.5 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast
10.2 Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Country (2023-2028)
10.2.1 United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.2.2 Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.2.3 Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.2.4 Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.3 APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Region (2023-2028)
10.3.1 China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.3.2 Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.3.3 Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.3.4 Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.3.5 India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.3.6 Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.4 Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Country (2023-2028)
10.4.1 Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.4.2 France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.4.3 UK Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.4.4 Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.4.5 Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.5 Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Region (2023-2028)
10.5.1 Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.5.2 South Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.5.3 Israel Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.5.4 Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.5.5 GCC Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Forecast
10.6 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Type (2023-2028)
10.7 Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Amgen Inc
11.1.1 Amgen Inc Company Information
11.1.2 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.1.3 Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Amgen Inc Main Business Overview
11.1.5 Amgen Inc Latest Developments
11.2 Amorepacific Corp
11.2.1 Amorepacific Corp Company Information
11.2.2 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.2.3 Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Amorepacific Corp Main Business Overview
11.2.5 Amorepacific Corp Latest Developments
11.3 BCN Peptides SA
11.3.1 BCN Peptides SA Company Information
11.3.2 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.3.3 BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 BCN Peptides SA Main Business Overview
11.3.5 BCN Peptides SA Latest Developments
11.4 Centrexion Therapeutics Corp
11.4.1 Centrexion Therapeutics Corp Company Information
11.4.2 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.4.3 Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Centrexion Therapeutics Corp Main Business Overview
11.4.5 Centrexion Therapeutics Corp Latest Developments
11.5 Daewoong Pharmaceutical Co Ltd
11.5.1 Daewoong Pharmaceutical Co Ltd Company Information
11.5.2 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.5.3 Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Daewoong Pharmaceutical Co Ltd Main Business Overview
11.5.5 Daewoong Pharmaceutical Co Ltd Latest Developments
11.6 DoNatur GmbH
11.6.1 DoNatur GmbH Company Information
11.6.2 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.6.3 DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 DoNatur GmbH Main Business Overview
11.6.5 DoNatur GmbH Latest Developments
11.7 Flex Pharma Inc
11.7.1 Flex Pharma Inc Company Information
11.7.2 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.7.3 Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Flex Pharma Inc Main Business Overview
11.7.5 Flex Pharma Inc Latest Developments
11.8 Grunenthal GmbH
11.8.1 Grunenthal GmbH Company Information
11.8.2 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.8.3 Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Grunenthal GmbH Main Business Overview
11.8.5 Grunenthal GmbH Latest Developments
11.9 Kyowa Hakko Kirin Co Ltd
11.9.1 Kyowa Hakko Kirin Co Ltd Company Information
11.9.2 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.9.3 Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Kyowa Hakko Kirin Co Ltd Main Business Overview
11.9.5 Kyowa Hakko Kirin Co Ltd Latest Developments
11.10 Medifron DBT Co Ltd
11.10.1 Medifron DBT Co Ltd Company Information
11.10.2 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.10.3 Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Medifron DBT Co Ltd Main Business Overview
11.10.5 Medifron DBT Co Ltd Latest Developments
11.11 Neurim Pharmaceuticals Ltd
11.11.1 Neurim Pharmaceuticals Ltd Company Information
11.11.2 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.11.3 Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Neurim Pharmaceuticals Ltd Main Business Overview
11.11.5 Neurim Pharmaceuticals Ltd Latest Developments
11.12 Pila Pharma AB
11.12.1 Pila Pharma AB Company Information
11.12.2 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.12.3 Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Pila Pharma AB Main Business Overview
11.12.5 Pila Pharma AB Latest Developments
11.13 Sylentis SAU
11.13.1 Sylentis SAU Company Information
11.13.2 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.13.3 Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Sylentis SAU Main Business Overview
11.13.5 Sylentis SAU Latest Developments
11.14 Toray Industries Inc
11.14.1 Toray Industries Inc Company Information
11.14.2 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.14.3 Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Toray Industries Inc Main Business Overview
11.14.5 Toray Industries Inc Latest Developments
11.15 Vitality Biopharma Inc
11.15.1 Vitality Biopharma Inc Company Information
11.15.2 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
11.15.3 Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Vitality Biopharma Inc Main Business Overview
11.15.5 Vitality Biopharma Inc Latest Developments
12 Research Findings and Conclusion
Table 1. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of CMX-020
Table 3. Major Players of CA-016
Table 4. Major Players of DD-04107
Table 5. Major Players of Others
Table 6. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)
Table 9. Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)
Table 12. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Player (2020-2022)
Table 14. Transient Receptor Potential Cation Channel Subfamily V Member 1 Key Players Head office and Products Offered
Table 15. Transient Receptor Potential Cation Channel Subfamily V Member 1 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Regions (2017-2022)
Table 20. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Country (2017-2022)
Table 22. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)
Table 24. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)
Table 26. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Region (2017-2022)
Table 28. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)
Table 30. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)
Table 32. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Country (2017-2022)
Table 34. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)
Table 36. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Transient Receptor Potential Cation Channel Subfamily V Member 1
Table 45. Key Market Challenges & Risks of Transient Receptor Potential Cation Channel Subfamily V Member 1
Table 46. Key Industry Trends of Transient Receptor Potential Cation Channel Subfamily V Member 1
Table 47. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share Forecast by Application (2023-2028)
Table 53. Amgen Inc Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 54. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 55. Amgen Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Amgen Inc Main Business
Table 57. Amgen Inc Latest Developments
Table 58. Amorepacific Corp Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 59. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 60. Amorepacific Corp Main Business
Table 61. Amorepacific Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Amorepacific Corp Latest Developments
Table 63. BCN Peptides SA Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 64. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 65. BCN Peptides SA Main Business
Table 66. BCN Peptides SA Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. BCN Peptides SA Latest Developments
Table 68. Centrexion Therapeutics Corp Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 69. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 70. Centrexion Therapeutics Corp Main Business
Table 71. Centrexion Therapeutics Corp Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Centrexion Therapeutics Corp Latest Developments
Table 73. Daewoong Pharmaceutical Co Ltd Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 74. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 75. Daewoong Pharmaceutical Co Ltd Main Business
Table 76. Daewoong Pharmaceutical Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Daewoong Pharmaceutical Co Ltd Latest Developments
Table 78. DoNatur GmbH Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 79. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 80. DoNatur GmbH Main Business
Table 81. DoNatur GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. DoNatur GmbH Latest Developments
Table 83. Flex Pharma Inc Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 84. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 85. Flex Pharma Inc Main Business
Table 86. Flex Pharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Flex Pharma Inc Latest Developments
Table 88. Grunenthal GmbH Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 89. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 90. Grunenthal GmbH Main Business
Table 91. Grunenthal GmbH Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Grunenthal GmbH Latest Developments
Table 93. Kyowa Hakko Kirin Co Ltd Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 94. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 95. Kyowa Hakko Kirin Co Ltd Main Business
Table 96. Kyowa Hakko Kirin Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Kyowa Hakko Kirin Co Ltd Latest Developments
Table 98. Medifron DBT Co Ltd Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 99. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 100. Medifron DBT Co Ltd Main Business
Table 101. Medifron DBT Co Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Medifron DBT Co Ltd Latest Developments
Table 103. Neurim Pharmaceuticals Ltd Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 104. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 105. Neurim Pharmaceuticals Ltd Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. Neurim Pharmaceuticals Ltd Main Business
Table 107. Neurim Pharmaceuticals Ltd Latest Developments
Table 108. Pila Pharma AB Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 109. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 110. Pila Pharma AB Main Business
Table 111. Pila Pharma AB Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Pila Pharma AB Latest Developments
Table 113. Sylentis SAU Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 114. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 115. Sylentis SAU Main Business
Table 116. Sylentis SAU Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. Sylentis SAU Latest Developments
Table 118. Toray Industries Inc Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 119. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 120. Toray Industries Inc Main Business
Table 121. Toray Industries Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. Toray Industries Inc Latest Developments
Table 123. Vitality Biopharma Inc Details, Company Type, Transient Receptor Potential Cation Channel Subfamily V Member 1 Area Served and Its Competitors
Table 124. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Product Offered
Table 125. Vitality Biopharma Inc Main Business
Table 126. Vitality Biopharma Inc Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 127. Vitality Biopharma Inc Latest Developments
List of Figures
Figure 1. Transient Receptor Potential Cation Channel Subfamily V Member 1 Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type in 2021
Figure 7. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Ophthalmology
Figure 8. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Ophthalmology (2017-2022) & ($ Millions)
Figure 9. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Immunology
Figure 10. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Immunology (2017-2022) & ($ Millions)
Figure 11. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Muscle Spasm
Figure 12. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Muscle Spasm (2017-2022) & ($ Millions)
Figure 13. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Pruritus
Figure 14. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Pruritus (2017-2022) & ($ Millions)
Figure 15. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Abdominal Pain
Figure 16. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Abdominal Pain (2017-2022) & ($ Millions)
Figure 17. Transient Receptor Potential Cation Channel Subfamily V Member 1 in Others
Figure 18. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market: Others (2017-2022) & ($ Millions)
Figure 19. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application in 2021
Figure 20. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Revenue Market Share by Player in 2021
Figure 21. Global Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2017-2022 ($ Millions)
Figure 23. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2017-2022 ($ Millions)
Figure 24. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2017-2022 ($ Millions)
Figure 26. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Value Market Share by Country in 2021
Figure 27. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Consumption Market Share by Type in 2021
Figure 28. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application in 2021
Figure 29. United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Region in 2021
Figure 34. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application in 2021
Figure 35. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Country in 2021
Figure 42. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type in 2021
Figure 43. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application in 2021
Figure 44. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Market Share by Application in 2021
Figure 52. Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 58. APAC Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 59. Europe Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 61. United States Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 62. Canada Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 65. China Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 66. Japan Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 67. Korea Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 69. India Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 70. Australia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 71. Germany Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 72. France Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 73. UK Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 74. Italy Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 75. Russia Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 76. Spain Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 79. Israel Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Transient Receptor Potential Cation Channel Subfamily V Member 1 Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...